Literature DB >> 7655347

Chemical modulation of metallothionein I and III mRNA in mouse brain.

H Zheng1, N E Berman, C D Klaassen.   

Abstract

Metallothioneins (MTs) are sulfhydryl-rich proteins. MT-I and MT-II are found in all tissues of the body, while MT-III exists only in brain. Regulation of MT-I and MT-III mRNA was studied in brain and liver of control C57BL/6J mice and mice given chemicals known to increase MT-I, namely, lipopolysaccharide (LPS), zinc chloride (Zn), cadmium chloride (Cd), dexamethasone (Dex), ethanol, and kainic acid (KA). Northern blot analysis revealed that MT-I mRNA levels in liver were induced dramatically (12-27-fold over basal levels) by all of the chemicals, while in brain only LPS produced an increase in MT-I mRNA (2-fold). Interestingly, the MT-I inducers, Cd, Dex, ethanol, and KA, down-regulated brain MT-III mRNA levels by approx. 30%. Because brain is such a heterogenous tissue, in situ hybridization was used to localize MT-I and MT-III mRNA in control and treated mice. MT-I mRNA signal, which was most abundant in the glial cells of the Purkinje cell layer of the cerebellum in control mice, appeared to be enhanced in mice given the MT-I inducers (LPS, Zn, Cd, Dex, ethanol, and KA). MT-I mRNA hybridization signal was also enhanced in the olfactory bulbs from LPS- and Cd-treated mice, while this signal was present but weak in control brains. MT-III mRNA hybridization signals were localized in hippocampus and co-localized with MT-I message in the glial cells of the Purkinje cell layer of the cerebellum. In addition, diffuse MT-III mRNA signals were visible in areas of the cerebral cortex, and in the molecular layer of the cerebellum. Signals for MT-III in hippocampus appeared to be reduced by KA, Dex and LPS treatment, while in the cortical region, MT-III mRNA signals appeared to be enhanced by KA, Cd, and ethanol treatment. In conclusion, both MT-I and MT-III expression in brain appears to be modulated by exogenous treatment, however, the changes are small in relation to those observed in liver. Chemical-induced alterations of MT mRNA are non-uniform throughout the brain, and thus best studied in a region-specific manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655347     DOI: 10.1016/0197-0186(94)00167-s

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

1.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 2.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

3.  Metallothionein inducers protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice.

Authors:  P Rojas; C Ríos
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

4.  Metallothioneins and brain injury: What transgenic mice tell us.

Authors:  Juan Hidalgo
Journal:  Environ Health Prev Med       Date:  2004-05       Impact factor: 3.674

5.  Influence of zinc sulfate intake on acute ethanol-induced liver injury in rats.

Authors:  Sema Bolkent; Pelin Arda-Pirincci; Sehnaz Bolkent; Refiye Yanardag; Sevim Tunali; Sukriye Yildirim
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

6.  Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide.

Authors:  Adolfo Sequeira; Ling Morgan; David M Walsh; Preston M Cartagena; Prabhakara Choudary; Jun Li; Alan F Schatzberg; Stanley J Watson; Huda Akil; Richard M Myers; Edward G Jones; William E Bunney; Marquis P Vawter
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

7.  Function of Metallothionein-3 in Neuronal Cells: Do Metal Ions Alter Expression Levels of MT3?

Authors:  Jamie Bousleiman; Alexa Pinsky; Sohee Ki; Angela Su; Irina Morozova; Sergey Kalachikov; Amen Wiqas; Rae Silver; Mary Sever; Rachel Narehood Austin
Journal:  Int J Mol Sci       Date:  2017-05-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.